NeuroOne Medical Technologies Corporation Recognition of Deferred Revenue
NeuroOne Medical Technologies Corporation (NMTC) reported Recognition of Deferred Revenue of -$1.46 million for the 9-month period ending 2023-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Income Statement › Other Income
us-gaap:RecognitionOfDeferredRevenue · last filed 2024-08-14
- NeuroOne Medical Technologies Corporation recognition of deferred revenue for the quarter ending 2023-06-30 was $0.00.
- NeuroOne Medical Technologies Corporation recognition of deferred revenue for the quarter ending 2023-03-31 was $0.00.
- NeuroOne Medical Technologies Corporation recognition of deferred revenue for the quarter ending 2022-12-31 was -$1.46M.
| Period end | Recognition of Deferred Revenue 3 month | Recognition of Deferred Revenue 6 month | Recognition of Deferred Revenue 9 month |
|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-14 | $0.00 derived: sum of 2 quarters · filed 2024-08-14 | -$1.46M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-14 | -$1.46M 10-Q · filed 2024-05-14 | |
| 2022-12-31 | -$1.46M 10-Q · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |